List of bibliographic references indexed by Vaccine
Number of relevant bibliographic references: 101.
[20-40] [
0 - 20][
0 - 50][
40-60]
| Ident. | Authors (with country if any) | Title |
|---|
| 001881 (2002) |
| Research Abstract Program of the 20th Annual ACVIM Forum Dallas, TX, May 29‐June 1, 2002 |
| 001919 (2000) |
Mohit K. Baxi [Canada] ; Dirk Deregt [Canada] ; Jill Robertson [Canada] ; Lorne A. Babiuk [Canada] ; Tobias Schlapp [Allemagne] ; Suresh K. Tikoo [Canada] | Recombinant Bovine Adenovirus Type 3 Expressing Bovine Viral Diarrhea Virus Glycoprotein E2 Induces an Immune Response in Cotton Rats |
| 001925 (2000) |
Per Klemm [Danemark] ; Mark A. Schembri [Danemark] | Fimbriae assisted bacterial surface display of heterologous peptides |
| 001933 (1999) |
H. Lutz [Suisse] ; C. Leutenegger [Suisse] ; R. Hofmann-Lehmann [Suisse] | The role of polymerase chain reaction and its newer developments in feline medicine |
| 001934 (1999) |
Ann L. E Lindberg ; Stefan Alenius | Principles for eradication of bovine viral diarrhoea virus (BVDV) infections in cattle populations |
| 001937 (1999) |
Douglas S. Zatechka Jr. [États-Unis] ; Nagendra R. Hegde [États-Unis] ; Kandasamy Hariharan [États-Unis] ; S. Srikumaran [États-Unis] | Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1 |
| 001960 (1998) |
F. M. Fernandez [États-Unis, Argentine] ; M. E. Conner [États-Unis] ; D. C. Hodgins [États-Unis] ; A. V. Parwani [États-Unis] ; P. R. Nielsen [États-Unis] ; S. E. Crawford [Argentine] ; M. K. Estes [Argentine] ; L. J. Saif [États-Unis] | Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines |
| 001983 (1997) |
Terecita D. Yule [États-Unis] ; Mark B. Roth [États-Unis] ; Kimberly Dreier [États-Unis] ; Anthony F. Johnson [États-Unis] ; Melissa Palmer-Densmore [États-Unis] ; Kris Simmons [États-Unis] ; Robert Fanton [États-Unis] | Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease |
| 001988 (1997) |
| Research Abstract Program of the 15th Annual ACVIM Forum |
| 001A07 (1996) |
Bror Morein [Suède] ; María Villacrés-Eriksson [Suède] ; Anders Sjölander [Suède] ; Karin Lövgren Bengtsson [Suède] | Novel adjuvants and vaccine delivery systems |
| 001A27 (1995) |
| Preparation of a helicase region coded by hepatitis C virus; hepatitis C virus recombinant helicase production via gene cloning and expression in Spodoptera frugiperda insect cell culture using baculovirus vector |
| 001A28 (1995) |
| Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease |
| 001A29 (1995) |
| New epitope-bearing portions of Entamoeba histolytica ; recombinant non-glycosylated epitope production and expression in prokaryote host cell, for application in a recombinant vaccine |
| 001A31 (1995) |
| Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine |
| 001A40 (1995) |
Isabel S. Novella [États-Unis] ; Esteban Domingo ; John J. Holland [États-Unis] | Rapid viral quasispecies evolution: implications for vaccine and drug strategies |
| 001A64 (1994) |
James J. Rusthoven [Canada] | Biological response modifiers and infectious diseases: Actual and potential therapeutic agents |
| 001A83 (1993) |
| Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy |
| 001A84 (1993) |
Charles M. Poser [États-Unis] | The pathogenesis of multiple sclerosis |
| 001A87 (1993) |
| Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle |
| 001A89 (1993) |
| Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis |
| 001A90 (1993) |
| Patent bibliography |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Vaccine"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i \
-Sk "Vaccine" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Main
|étape= Exploration
|type= indexItem
|index= Teeft.i
|clé= Vaccine
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021 |  |
